Хайлтын үр дүнгүүд - Yoshio Sumida
- 32-н 1 - 20 үр дүнгүүдийг харуулж байна
- Дараагийн хуудас руу очих
-
1
-
2
Current and future pharmacological therapies for NAFLD/NASH -н Yoshio Sumida, Masashi Yoneda
Хэвлэсэн 2017Revisão -
3
Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non‐alcoholic fatty liver disease: A prospective, single‐arm trial (LEAD trial) -н Yoshio Sumida, Kenta Murotani, Miyoko Saito, Atsuko Tamasawa, Yusuke Osonoi, Masashi Yoneda, Takeshi Osonoi
Хэвлэсэн 2018Artigo -
4
The Impact of PNPLA3 rs738409 Genetic Polymorphism and Weight Gain ≥10 kg after Age 20 on Non-Alcoholic Fatty Liver Disease in Non-Obese Japanese Individuals -н Kenichi Nishioji, Naomi Mochizuki, Masao Kobayashi, Mai Kamaguchi, Yoshio Sumida, Takeshi Nishimura, Kanji Yamaguchi, Hiroshi Kadotani, Yoshito Itoh
Хэвлэсэн 2015Artigo -
5
-
6
Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods -н Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuji Ogawa, Yuichiro Eguchi, Yoshio Sumida, Masashi Yoneda, Miwa Kawanaka, Satoru Saito, Katsutoshi Tokushige, Atsushi Nakajima
Хэвлэсэн 2017Revisão -
7
Efficacy and safety of canagliflozin in type 2 diabetes mellitus patients with biopsy-proven nonalcoholic steatohepatitis classified as stage 1–3 fibrosis -н Yuya Seko, Taichiro Nishikawa, Atsushi Umemura, Kanji Yamaguchi, Michihisa Moriguchi, Kohichiroh Yasui, Mayumi Kimura, Hiroaki Iijima, Toshio Hashimoto, Yoshio Sumida, Takeshi Okanoue, Yoshito Itoh
Хэвлэсэн 2018Artigo -
8
Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease -н Yoshio Sumida, Toshiaki Nakashima, Takaharu Yoh, Masanori Furutani, Akihisa Hirohama, Yuko Kakisaka, Yoshiki Nakajima, Hiroki Ishikawa, Hironori Mitsuyoshi, Takeshi Okanoue, Kei Kashima, Hajime Nakamura, Junji Yodoi
Хэвлэсэн 2002Artigo -
9
Patient‐reported outcomes in patients with non‐alcoholic fatty liver disease: A narrative review of Chronic Liver Disease Questionnaire‐non‐alcoholic fatty liver disease/non‐alcoho... -н Sakura Yamamura, Dan Nakano, Ryuki Hashida, Tsubasa Tsutsumi, Takumi Kawaguchi, Michiaki Okada, Hiroshi Isoda, Hirokazu Takahashi, Hiroo Matsuse, Yuichiro Eguchi, Yoshio Sumida, Atsushi Nakajima, Lynn H. Gerber, Zobair M. Younossi, Takuji Torimura
Хэвлэсэн 2020Revisão -
10
Characteristics of Patients With Nonalcoholic Steatohepatitis Who Develop Hepatocellular Carcinoma -н Kohichiroh Yasui, Etsuko Hashimoto, Yasuji Komorizono, Kazuhiko Koike, Shigeki Arii, Yasuharu Imai, Toshihide Shima, Yoshihiro Kanbara, Toshiji Saibara, Takahiro Mori, Sumio Kawata, Hirofumi Uto, Shiro Takami, Yoshio Sumida, Toshinari Takamura, Miwa Kawanaka, Takeshi Okanoue
Хэвлэсэн 2011Artigo -
11
Palmitate-induced lipotoxicity is crucial for the pathogenesis of nonalcoholic fatty liver disease in cooperation with gut-derived endotoxin -н Yuji Ogawa, Kento Imajo, Yasushi Honda, Takaomi Kessoku, Wataru Tomeno, Shingo Kato, Koji Fujita, Masato Yoneda, Satoru Saito, Yusuke Saigusa, Hideyuki Hyogo, Yoshio Sumida, Yoshito Itoh, Kosei Eguchi, Takeharu Yamanaka, Koichiro Wada, Atsushi Nakajima
Хэвлэсэн 2018Artigo -
12
Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population -н Yoshio Sumida, Masato Yoneda, Hideyuki Hyogo, Yoshito Itoh, Masafumi Ono, Hideki Fujii, Yuichiro Eguchi, Yasuaki Suzuki, Noriaki Aoki, Kazuyuki Kanemasa, Koji Fujita, Kazuaki Chayama, Toshiji Saibara, Norifumi Kawada, Kazuma Fujimoto, Yutaka Kohgo, Toshikazu Yoshikawa, Takeshi Okanoue
Хэвлэсэн 2012Artigo -
13
LDL-Migration Index (LDL-MI), an Indicator of Small Dense Low-Density Lipoprotein (sdLDL), Is Higher in Non-Alcoholic Steatohepatitis than in Non-Alcoholic Fatty Liver: A Multicent... -н Kento Imajo, Hideyuki Hyogo, Masato Yoneda, Yasushi Honda, Takaomi Kessoku, Wataru Tomeno, Yuji Ogawa, Masataka Taguri, Hironori Mawatari, Yuichi Nozaki, Koji Fujita, Hiroyuki Kirikoshi, Satoru Saito, Yoshio Sumida, Masafumi Ono, Koichiro Wada, Atsushi Nakajima, Yuichiro Eguchi
Хэвлэсэн 2014Artigo -
14
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography -н Kento Imajo, Takaomi Kessoku, Yasushi Honda, Wataru Tomeno, Yuji Ogawa, Hironori Mawatari, Koji Fujita, Masato Yoneda, Masataka Taguri, Hideyuki Hyogo, Yoshio Sumida, Masafumi Ono, Yuichiro Eguchi, Tomio Inoue, Takeharu Yamanaka, Koichiro Wada, Satoru Saito, Atsushi Nakajima
Хэвлэсэн 2015Artigo -
15
Use of Mac‐2 binding protein as a biomarker for nonalcoholic fatty liver disease diagnosis -н Yoshihiro Kamada, Masafumi Ono, Hideyuki Hyogo, Hideki Fujii, Yoshio Sumida, Makoto Yamada, Kojiroh Mori, Saiyu Tanaka, Tomohiro Maekawa, Yusuke Ebisutani, Akiko Yamamoto, Shinji Takamatsu, Masashi Yoneda, Norifumi Kawada, Kazuaki Chayama, Toshiji Saibara, Tetsuo Takehara, Eiji Miyoshi
Хэвлэсэн 2017Artigo -
16
Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis -н Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono, Yuichi Nozaki, Hideyuki Hyogo, Masahiro Koseki, Yuichi Yoshida, Takumi Kawaguchi, Yoshihiro Kamada, Takeshi Okanoue, Atsushi Nakajima
Хэвлэсэн 2020Revisão -
17
FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic -н Yoshio Sumida, Masashi Yoneda, Katsutoshi Tokushige, Miwa Kawanaka, Hideki Fujii, Masato Yoneda, Kento Imajo, Hirokazu Takahashi, Yuichiro Eguchi, Masafumi Ono, Yuichi Nozaki, Hideyuki Hyogo, Masahiro Koseki, Yuichi Yoshida, Takumi Kawaguchi, Yoshihiro Kamada, Takeshi Okanoue, Atsushi Nakajima
Хэвлэсэн 2021Revisão -
18
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis -н Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, Hirofumi Uto, Masafumi Ono, Yoshio Sumida, Masataka Seike, Yoshiyuki Takei, Tetsuo Takehara, Katsutoshi Tokushige, Atsushi Nakajima, Masashi Yoneda, Toshiji Saibara, Goshi Shiota, Isao Sakaida, Makoto Nakamuta, Toshihiko Mizuta, Hirohito Tsubouchi, Kentaro Sugano, Tooru Shimosegawa
Хэвлэсэн 2015Artigo -
19
Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese -н Takahisa Kawaguchi, Yoshio Sumida, Atsushi Umemura, Keitaro Matsuo, Meiko Takahashi, Toshinari Takamura, Kohichiroh Yasui, Toshiji Saibara, Etsuko Hashimoto, Miwa Kawanaka, Sumio Watanabe, Sumio Kawata, Yasuharu Imai, Miki Kokubo, Toshihide Shima, Hyohun Park, Hideo Tanaka, Kazuo Tajima, Ryo Yamada, Fumihiko Matsuda
Хэвлэсэн 2012Artigo -
20
Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis -н Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, Hirofumi Uto, Masafumi Ono, Yoshio Sumida, Masataka Seike, Yoshiyuki Takei, Tetsuo Takehara, Katsutoshi Tokushige, Atsushi Nakajima, Masashi Yoneda, Toshiji Saibara, Goshi Shiota, Isao Sakaida, Makoto Nakamuta, Toshihiko Mizuta, Hirohito Tsubouchi, Kentaro Sugano, Tooru Shimosegawa
Хэвлэсэн 2015Artigo
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Internal medicine
Medicine
Disease
Fatty liver
Gastroenterology
Nonalcoholic fatty liver disease
Steatohepatitis
Fibrosis
Endocrinology
Cirrhosis
Biology
Biopsy
Diabetes mellitus
Liver biopsy
Hepatocellular carcinoma
Hepatology
Obesity
Pathology
Chronic liver disease
Liver disease
Nonalcoholic steatohepatitis
Environmental health
Population
Steatosis
Transient elastography
Type 2 diabetes
Metabolic syndrome
Paleontology
Radiology
Allele